Related Experiment Video
Updated: Jan 5, 2026
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Closing the Loop: Validation of Implantable Cardiac Devices With Computational Heart Models
Insights
A new framework tests cardiovascular implantable electronic devices (CIEDs) using a computational heart model. This in-silico closed-loop testing ensures CIED safety and efficacy across diverse patient physiological conditions.
Area of Science:
- Biomedical Engineering
- Computational Physiology
- Medical Device Development
Background:
- Cardiovascular Implantable Electronic Devices (CIEDs) are crucial for managing life-threatening cardiac conditions like bradycardia and heart failure.
- Patient physiological variability presents significant challenges for the development and validation of CIEDs.
Purpose of the Study:
- To introduce an automated, in-silico framework for validating CIEDs.
- To enable closed-loop testing of CIEDs integrated with a computational heart model.
Main Methods:
- Development of an automated framework for CIED validation.
- Integration of a physiologically based computational heart model for closed-loop simulation.
- Utilizing a stochastic optimization algorithm for exploring diverse physiological conditions.
Main Results:
- The closed-loop framework achieved high system test coverage.
- The computational heart model generated clinically relevant responses.
- Simulated pacemaker-mediated tachycardia risk aligned with clinical observations, and device programming impacts were demonstrated.
Conclusions:
- Model-based closed-loop testing of CIEDs is effective for assessing safety and efficacy.
- This approach provides crucial insights under specific physiological constraints.
- The framework aids in optimizing device programming for improved treatment outcomes.
Objective:
Cardiovascular Implantable Electronic Devices (CIEDs) are used extensively for treating life-threatening conditions such as bradycardia, atrioventricular block and heart failure. The complicated heterogeneous physical dynamics of patients provide distinct challenges to device development and validation. We address this problem by proposing a device testing framework within the in-silico closed-loop context of patient physiology.
Methods:
We develop an automated framework to validate CIEDs in closed-loop with a high-level physiologically based computational heart model. The framework includes test generation, execution and evaluation, which automatically guides an integrated stochastic optimization algorithm for exploration of physiological conditions.
Conclusion:
The results show that using a closed loop device-heart model framework can achieve high system test coverage, while the heart model provides clinically relevant responses. The simulated findings of pacemaker mediated tachycardia risk evaluation agree well with the clinical observations. Furthermore, we illustrate how device programming parameter selection affects the treatment efficacy for specific physiological conditions.
Significance:
This work demonstrates that incorporating model based closed-loop testing of CIEDs into their design provides important indications of safety and efficacy under constrained physiological conditions.
